tiprankstipranks
Trending News
More News >
Todos Medical (TOMDF)
:TOMDF
US Market

Todos Medical (TOMDF) Price & Analysis

Compare
71 Followers

TOMDF Stock Chart & Stats


---

Financials

TOMDF FAQ

What was Todos Medical ’s price range in the past 12 months?
Currently, no data Available
What is Todos Medical ’s market cap?
Todos Medical ’s market cap is $1.41K.
    When is Todos Medical ’s upcoming earnings report date?
    The company’s upcoming earnings report date is not yet available.
    How were Todos Medical ’s earnings last quarter?
    Todos Medical released its earnings results on Aug 23, 2022. The company reported -$0.006 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.006.
      Is Todos Medical overvalued?
      According to Wall Street analysts Todos Medical ’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Todos Medical pay dividends?
        Todos Medical does not currently pay dividends.
        What is Todos Medical ’s EPS estimate?
        Todos Medical ’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Todos Medical have?
        Todos Medical has 1,408,127,200 shares outstanding.
          What happened to Todos Medical ’s price movement after its last earnings report?
          Todos Medical reported an EPS of -$0.006 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
            Which hedge fund is a major shareholder of Todos Medical ?
            Currently, no hedge funds are holding shares in TOMDF
            ---

            Company Description

            Todos Medical

            Todos Medical Ltd., a vitro diagnostics company, develops and commercializes blood tests for the detection of cancer and Alzheimer disease in the United States. The company develops Total Biochemical Infrared Analysis, a proprietary cancer-screening technology using peripheral blood spectroscopy analysis for examination into cancer's influence on the immune system; Lymphocyte Proliferation Test, a diagnostic blood test that determines the ability of peripheral blood lymphocytes and monocytes to withstand an exogenous mitogenic stimulation that induces them to enter the cell cycle; and blood tests for the detection of neurodegenerative disorders, such as Alzheimer's disease. Its cancer screening and diagnosis products include TM-B1 and TM-B2 for breast cancer tests; and TMC blood test for the screening and diagnosis of colon cancer. The company also offers Tollovid, a 3CL protease inhibitor dietary supplement to support healthy immune function against circulating coronaviruses; and Tollovir, an antiviral treatment for Covid-19 that is in Phase 2 clinical trial. Todos Medical Ltd. has a collaboration agreement with Integrated Health LLC, as well as has agreements with various companies to develop screening tests for SARS-nCoV-2; and to distribute certain COVID-19 test kits. Todos Medical Ltd. was incorporated in 2010 and is headquartered in Tel Aviv, Israel.
            ---
            Similar Stocks
            Company
            Price & Change
            Follow
            Applied DNA Sciences
            Precipio
            ENDRA Life Sciences
            iSpecimen
            bioAffinity Technologies, Inc.
            Popular Stocks
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis